journal article·2012-09

Polymer-coated mesoporous silica nanoparticles for the controlled release of macromolecules

Sanjib Bhattacharyya, Henson Wang, Paul Ducheyne

Acta Biomaterialia· Volume 8· Issue 9
Publisher page

Abstract

With the goal of achieving constant release of large biological molecules over an extended period of time we focused on hybrid inorganic/organic nanoparticles. We synthesized poly(ethylene glycol) (PEG)-coated mesoporous silica nanoparticles (MSNs) with incorporated trypsin inhibitor (TI), a model protein molecule for growth factors. Due to the goal of incorporating large protein molecules the pore size of the as-synthesized MSNs was expanded by a hydrothermal treatment prior to TI incorporation. In vitro release from the MSNs without the thin polymer film shows an initial burst followed by continuous release. In the case of polymer-coated MSNs the initial burst release was completely suppressed and approximate zero order release was achieved for 4 weeks.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Glycosylation and Glycoproteins Research · Polymer Surface Interaction Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (47)

Show source-provided references
1. Strategies in the design of nanoparticles for therapeutic applications10.1038/nrd2591 ↗
2. Biocompatible controlled release polymers for delivery of polypeptides and growth factors10.1002/jcb.240450406 ↗
3. Incorporation and release of fluoresce in isothiocyanate-linked dextrans from a bead-formed macroporous hydrophilic matrix with potential for sustained release10.1016/0142-9612(93)90016-U ↗
4. Novel preparation of poly(vinyl alcohol) microparticles without crosslinking agent for controlled drug delivery of proteins10.1016/0168-3659(93)90156-Y ↗
5. Physicochemical characterization of polymeric injectable implant delivery system10.1016/0168-3659(94)00097-E ↗
6. Recent studies and molecular analysis of drug release from swelling-controlled devices
7. Water-soluble dendritic-linear triblock copolymer-modified magnetic nanoparticles: preparation, characterization and drug release properties10.1039/c1jm11613d ↗
8. Hyperbranched polymer-drug conjugates with high drug payload for enhanced cellular delivery10.1007/s11095-004-7670-x ↗
9. MPEG-PLA microspheres with narrow size distribution increase the controlled release effect of recombinant human growth hormone10.1039/c1jm12643a ↗
10. Double-walled microspheres for drug delivery10.1557/PROC-331-97 ↗
11. Bioceramics: materials characteristics vs in vivo behavior
12. Bioactive material template for in vitro synthesis of bone tissue10.1002/jbm.820290311 ↗
13. Fabrication, characterization and evaluation of bioceramic hollow microspheres used as microcarriers for 3-D bone tissue formation in rotating bioreactors10.1016/S0142-9612(98)00183-5 ↗
14. Bone graft and bone graft substitutes: a review of current technology and applications10.1002/jab.770020307 ↗
15. In vitro release kinetics of biologically active transforming growth factorβ 1 from a novel xero-gel carrier10.1016/S0142-9612(97)00008-2 ↗
16. Newest factors in fracture healing10.1097/00003086-199204000-00036 ↗
17. Investigation of a hydroxyapatite and calcium sulfate composite supplemented with an osteo inductive factor10.1002/jbm.820240602 ↗
18. Chondroosteogenetic response to crude bone matrix proteins bound to hydroxyapatite10.1097/00003086-198704000-00030 ↗
19. Calcium phosphate ceramic coatings as carriers of vancomycin10.1016/S0142-9612(96)00190-1 ↗
20. Response of the mouse femoral muscle to an implant of a composite of bone morphogenetic protein and plaster of Paris10.1097/00003086-198809000-00043 ↗
21. Sol–gel carrier systems for controlled drug delivery10.1023/A:1008603622543 ↗
22. Sol–gel derived carrier for the controlled release of proteins10.1016/S0142-9612(99)00066-6 ↗
23. In vitro behavior of silica-based xerogels intended as controlled release carriers10.1111/j.1151-2916.1999.tb01861.x ↗
24. Effect of synthesis parameters of the sol–gel-processed spray-dried silica gel microparticles on the release rate of dexmedetomidine10.1016/S0142-9612(02)00016-9 ↗
25. In vivo tissue response to resorbable silica xerogels as controlled-release materials10.1016/j.biomaterials.2004.04.004 ↗
26. Nanostructural control of implantable xerogels for the controlled release of biomolecules
27. Revisiting silica based ordered mesoporous materials: medical applications10.1039/B509744D ↗
28. Vancomycin covalently bonded to titanium alloy prevents bacterial colonization10.1002/jor.20348 ↗
29. Emulsified sol–gel silica microspheres for controlled drug delivery10.1016/j.biomaterials.2008.09.066 ↗
30. Recent progress in the synthesis and applications of MCM-41 based mesoporous materials – a short review10.1080/17458080600812757 ↗
31. Effect of surfactant concentration on the morphology and texture of MCM-41 materials10.1021/jp800898n ↗
32. Beck JS, Chu CTW, Johnson ID, Kresge CT, Leonowicz ME, Roth WJ, et al. Synthetic porous crystalline material its synthesis and use. WO Patent No. 91-11 390, 1991.
33. Influence of pore size of MCM-41 matrices on drug delivery rate10.1016/j.micromeso.2003.12.012 ↗
34. Morphological control of room-temperature ionic liquid templated mesoporous silica nanoparticles for controlled release of antibacterial agents10.1021/nl048774r ↗
35. Confinement and controlled release of bisphosphonates on ordered mesoporous silica-based materials10.1021/ja062286z ↗
36. Supramolecular nano valves controlled by proton abstraction and competitive binding10.1021/cm061682d ↗
37. Construction of a pH-driven supramolecular nanovalve10.1021/ol0612509 ↗
38. A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules10.1021/ja028650l ↗
39. A reversible molecular valve10.1002/adma.200305165 ↗
40. An operational supramolecular nanovalve10.1021/ja039424u ↗
41. Photocontrolled reversible release of guest molecules from coumarin-modified mesoporous silica10.1038/nature01362 ↗
42. Highly efficient cellular labeling of mesoporous nanoparticles in human mesenchymal stem cells: implication for stem cell tracking10.1096/fj.05-4288fje ↗
43. Functionalized mesoporous silica nanoparticle-based drug delivery system to rescue acrolein-mediated cell death10.2217/17435889.3.4.507 ↗
44. Protein assay sensitive at nanogramlevels10.1016/0003-2697(87)90051-0 ↗
45. Small angle neutron scattering study of the structure and formation of ordered mesoporesin silica10.1557/PROC-371-47 ↗
46. 1982
47. Mechanism of sustained action medication: theoretical analysis of rate of release of solid drugs dispersed in solid matrices10.1002/jps.2600521210 ↗